Of the patients who completed the six-month study.

Of the patients who completed the six-month study, subjects demonstrated in the LaserComb treatment group significantly greater increase in in mean terminal treated hair density than subjects with the sham device. Commented commented further: ‘The results of the study an important goal by implementing a well-designed and controlled efficacy study achieved the results showed that the LaserComb is really efficient, convenient, well-tolerated treatment for hair loss Androgenic alopecia Androgenic alopecia in men. ‘.

Stillman also noted that male pattern baldness more than 50 million people in the U.S. And many more millions of people worldwide.Study Design and ResultsThe four-center, double-blind, sham unit was controlled trial believed.sults of randomized treatment of patients blinded to either the LaserComb or compare sham – device per a protocol of an Investigational Review Board approved and carried out in accordance with Good Clinical Practices. Subjects were required to provide a Norwood Hamilton Classifications of IIa based on the Male Classification have system of hair loss V, and have Fitzpatrick Skin Type Scale I to IV..Authors: Sandrine Joly, Christina Long, Markus Thiersch, Marijana Samardzija and Christian GrimmNews Tips and in the the Journal of Neuroscience Please click here to the current table of Filter.